Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.
J Vasc Access. 2022 Mar;23(2):275-279. doi: 10.1177/1129729821989904. Epub 2021 Jan 23.
Tunneled cuffed catheters (TCC) are generally used as a temporary means to provide hemodialysis (HD) until permanent arteriovenous access is established. However, certain complications are associated with use of TCCs such as infections, catheter malfunction/malposition or venous stenosis. Limited data is available on outcomes and long term complications associated with TCCs in our country. The aim of this study was to study the outcomes of TCCs and associated long term complications during the course of its usage.
We retrospectively studied case records of patients who had TCCs placed for HD at our institution, from January 2016 to June 2018.
A total of 116 TCCs were placed during the study period. The mean age of the population was 57.09 years; 58.6% were males. The right internal jugular vein (52.6%) was the most common site of TCC insertion followed by the left internal jugular vein (29.3%). Functioning TCCs were successfully removed in almost two-thirds of cases (65.7%) once their permanent access was mature. Development of catheter related blood stream infection (CRBSI) was seen in 22 patients (19.8%) requiring catheter removal in 14 (12.6%) patients. Mechanical complications leading to catheter removal were seen in seven patients (6.3%). The median catheter duration was 62.5 days ranging from 1 to 343 days.
TCCs, though associated with complications particularly CRBSI, are a viable option for short- to intermediate-term use for HD till the maturation of permanent arteriovenous access in a limited-resource setting.
经皮隧道带涤纶套导管(TCC)通常被用作建立永久性动静脉通路之前进行血液透析(HD)的临时手段。然而,TCC 的使用与某些并发症相关,如感染、导管故障/错位或静脉狭窄。在我国,有关 TCC 的结局和长期并发症的数据有限。本研究旨在研究 TCC 的结局及其在使用过程中的长期并发症。
我们回顾性研究了 2016 年 1 月至 2018 年 6 月期间在我院接受 TCC 置入 HD 的患者的病历记录。
在研究期间共置入了 116 根 TCC。患者的平均年龄为 57.09 岁;男性占 58.6%。TCC 最常插入的部位是右侧颈内静脉(52.6%),其次是左侧颈内静脉(29.3%)。一旦永久性通路成熟,近三分之二(65.7%)的患者能够成功地移除功能正常的 TCC。22 例(19.8%)患者出现导管相关血流感染(CRBSI),其中 14 例(12.6%)需要拔除导管。7 例(6.3%)患者出现机械并发症导致导管拔除。导管留置时间中位数为 62.5 天,范围为 1 至 343 天。
TCC 尽管与并发症相关,特别是 CRBSI,但在资源有限的情况下,对于 HD 的短期至中期使用,是一种可行的选择,直到永久性动静脉通路成熟。